Literature DB >> 32720073

Maternal Immune Activation Causes Schizophrenia-like Behaviors in the Offspring through Activation of Immune-Inflammatory, Oxidative and Apoptotic Pathways, and Lowered Antioxidant Defenses and Neuroprotection.

Pinku Mani Talukdar1, Fazal Abdul1, Michael Maes2,3,4, V S Binu5, Ganesan Venkatasubramanian6, Bindu M Kutty7, Monojit Debnath8.   

Abstract

Schizophrenia is a complex neuropsychiatric disorder, influenced by a combined action of genes and environmental factors. The neurodevelopmental origin is one of the most widely recognized etiological models of this heterogeneous disorder. Environmental factors, especially infections during gestation, appear to be a major risk determinant of neurodevelopmental basis of schizophrenia. Prenatal infection may cause maternal immune activation (MIA) and enhance risk of schizophrenia in the offspring. However, the precise mechanistic basis through which MIA causes long-lasting schizophrenia-like behavioral deficits in offspring remains inadequately understood. Herein, we aimed to delineate whether prenatal infection-induced MIA causes schizophrenia-like behaviors through its long-lasting effects on immune-inflammatory and apoptotic pathways, oxidative stress toxicity, and antioxidant defenses in the brain of offspring. Sprague-Dawley rats were divided into three groups (n = 15/group) and were injected with poly (I:C), LPS, and saline at gestational day (GD)-12. Except IL-1β, plasma levels of IL-6, TNF-α, and IL-17A assessed after 24 h were significantly elevated in both the poly (I:C)- and LPS-treated pregnant rats, indicating MIA. The rats born to dams treated with poly (I:C) and LPS displayed increased anxiety-like behaviors and significant deficits in social behaviors. Furthermore, the hippocampus of the offspring rats of both the poly (I:C)- and LPS-treated groups showed increased signs of lipid peroxidation, diminished total antioxidant content, and differentially upregulated expression of inflammatory (TNFα, IL6, and IL1β), and apoptotic (Bax, Cas3, and Cas9) genes but decreased expression of neuroprotective (BDNF and Bcl2) genes. The results suggest long-standing effects of prenatal infections on schizophrenia-like behavioral deficits, which are mediated by immune-inflammatory and apoptotic pathways, increased oxidative stress toxicity, and lowered antioxidant and neuroprotective defenses. The findings suggest that prenatal infections may underpin neurodevelopmental aberrations and neuroprogression and subsequently schizophrenia-like symptoms.

Entities:  

Keywords:  Inflammation; Maternal immune activation; Neuro-immune; Neuroprotection; Oxidative stress; Schizophrenia-like behaviors

Mesh:

Substances:

Year:  2020        PMID: 32720073     DOI: 10.1007/s12035-020-02028-8

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  16 in total

1.  Exposure to chronic stressor upsurges the excitability of serotoninergic neurons and diminishes concentrations of circulating corticosteroids in rats two weeks thereafter.

Authors:  Eliyahu Dremencov; Daniil Grinchii; Katarina Hrivikova; Maxim Lapshin; Maria Komelkova; Jan Graban; Agnesa Puhova; Olga Tseilikman; Vadim Tseilikman; Daniela Jezova
Journal:  Pharmacol Rep       Date:  2022-04-15       Impact factor: 3.024

2.  Interaction of maternal immune activation and genetic interneuronal inhibition.

Authors:  Allison Anderson; Thiago C Genaro-Mattos; Luke B Allen; Katalin Koczok; Zeljka Korade; Karoly Mirnics
Journal:  Brain Res       Date:  2021-02-15       Impact factor: 3.252

3.  Modestly increasing systemic interleukin-6 perinatally disturbs secondary germinal zone neurogenesis and gliogenesis and produces sociability deficits.

Authors:  Fernando Janczur Velloso; Anna Wadhwa; Ekta Kumari; Ioana Carcea; Ozlem Gunal; Steven W Levison
Journal:  Brain Behav Immun       Date:  2021-12-23       Impact factor: 7.217

4.  First Episode Psychosis and Schizophrenia Are Systemic Neuro-Immune Disorders Triggered by a Biotic Stimulus in Individuals with Reduced Immune Regulation and Neuroprotection.

Authors:  Michael Maes; Kitiporn Plaimas; Apichat Suratanee; Cristiano Noto; Buranee Kanchanatawan
Journal:  Cells       Date:  2021-10-28       Impact factor: 6.600

5.  Sex difference in the interrelationship between TNF-α and oxidative stress status in first-episode drug-naïve schizophrenia.

Authors:  Minghuan Zhu; Zhenjing Liu; Yanhong Guo; Mst Sadia Sultana; Kang Wu; Xiaoe Lang; Qinyu Lv; Xiao Huang; Zhenghui Yi; Zezhi Li
Journal:  J Neuroinflammation       Date:  2021-09-15       Impact factor: 8.322

6.  Transgenerational Sex-dependent Disruption of Dopamine Function Induced by Maternal Immune Activation.

Authors:  Michele Santoni; Roberto Frau; Marco Pistis
Journal:  Front Pharmacol       Date:  2022-02-08       Impact factor: 5.810

7.  Reduced Serum Levels of Soluble Interleukin-15 Receptor α in Schizophrenia and Its Relationship to the Excited Phenotype.

Authors:  Yi He; Qijing Bo; Zhen Mao; Jian Yang; Min Liu; Haixia Wang; Abba J Kastin; Weihong Pan; Chuanyue Wang; Zuoli Sun
Journal:  Front Psychiatry       Date:  2022-03-09       Impact factor: 4.157

8.  False Dogmas in Schizophrenia Research: Toward the Reification of Pathway Phenotypes and Pathway Classes.

Authors:  Michael Maes; George Anderson
Journal:  Front Psychiatry       Date:  2021-06-17       Impact factor: 4.157

Review 9.  LPS versus Poly I:C model: comparison of long-term effects of bacterial and viral maternal immune activation on the offspring.

Authors:  Mian Bao; Naomi Hofsink; Torsten Plösch
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2021-12-07       Impact factor: 3.619

10.  A Characterization of the Effects of Minocycline Treatment During Adolescence on Structural, Metabolic, and Oxidative Stress Parameters in a Maternal Immune Stimulation Model of Neurodevelopmental Brain Disorders.

Authors:  Diego Romero-Miguel; Marta Casquero-Veiga; Karina S MacDowell; Sonia Torres-Sanchez; José Antonio Garcia-Partida; Nicolás Lamanna-Rama; Ana Romero-Miranda; Esther Berrocoso; Juan C Leza; Manuel Desco; María Luisa Soto-Montenegro
Journal:  Int J Neuropsychopharmacol       Date:  2021-09-21       Impact factor: 5.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.